Biomarker Assay Validation in Healthy Smokers and COPD Smokers and Ex-smokers
NCT02490358 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2016-02-03
Summary
This study will collect sputum samples from healthy smokers, COPD smokers and COPD ex-smokers to analyse biomarkers of inflammation
Conditions
Sponsors & Collaborators
-
Babraham Institute Enterprise Limited
collaborator OTHER -
Respivert Ltd
lead INDUSTRY
Principal Investigators
-
Ginny Norris, Dr · Respivert Ltd
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-06-30
- Primary Completion
- 2016-01-31
- Completion
- 2016-01-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Biomarkers of Chronic Obstructive Pulmonary Disease
NCT04963023 ·Status: COMPLETED
-
Biomarkers of Early Chronic Obstructive Pulmonary Disease (COPD) in Smokers - Longitudinal Study
NCT02076061 ·Status: COMPLETED
-
Genomic/ Proteomic/ Metabonomic Profiling in Chronic Obstructive Pulmonary Disease (COPD)
NCT00655694 ·Status: WITHDRAWN
-
A Cross Sectional, Diagnostic Accuracy Study to Validate the Use of a New Device(Inflammacheck™) in Diagnosing COPD
NCT04024657 ·Status: COMPLETED
-
Biomarkers of iNOS Activity in COPD, Asthma, Healthy Control
NCT00159302 ·Status: WITHDRAWN
-
A Translational Study for Prediction of Biomarkers and Identification of Phenotype and Endotype of COPD and Early COPD Outcomes in Chinese Population
NCT06724848 ·Status: RECRUITING
-
Biomarkers for Diagnosis and Treatment of COPD
NCT02633280 ·Status: COMPLETED
-
Small Bioactive Molecules in Early COPD Diseases
NCT04950023 ·Status: UNKNOWN
-
Optimization of Exhaled Biomarker Collection and Analysis
NCT05322785 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Characteristics That Identify Exacerbation Risk Following Colds in COPD Patients
NCT01376830 ·Status: COMPLETED
-
A Study to Evaluate Biomarkers in Chronic Obstructive Pulmonary Disease
NCT01268072 ·Status: TERMINATED
-
A Pilot Study to Characterise Saliva and Sputum FTIR Spectral Profiles in Patients with COPD During Exacerbations and When Stable
NCT04524819 ·Status: TERMINATED
-
Markers of COPD Exacerbations
NCT05315674 ·Status: RECRUITING
-
Respiratory Pathogens of Patients With Asthma and COPD Exacerbations
NCT02866357 ·Status: COMPLETED
-
Identifying Inflammatory Biomarkers of Chronic Obstructive Pulmonary Disease
NCT00394940 ·Status: COMPLETED
-
Sentinel - Triaging Acute Breathlessness Using Multi-Modal Biomarkers
NCT05304494 ·Status: WITHDRAWN
-
COPD in the Time of COVID-19
NCT04407598 ·Status: UNKNOWN
-
Lung Health of Early COPD: A Multi-center Cohort Study
NCT05466396 ·Status: RECRUITING
-
Biomarkers in Chronic Obstructive Pulmonary Disease (COPD)
NCT01145300 ·Status: COMPLETED
-
Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)
NCT02719184 ·Status: COMPLETED
-
European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00722267 ·Status: COMPLETED
-
Study of COPD Subgroups and Biomarkers
NCT01969344 ·Status: ACTIVE_NOT_RECRUITING
-
Follow-up-study of COPD Patients and Healthy Controls for Evaluation of Predictive Non-coding RNA Biomarkers
NCT02522026 ·Status: COMPLETED
-
Chronic Obstructive Pulmonary Disease Biomarker Study
NCT02050022 ·Status: UNKNOWN
-
Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease, in Asia Pacific
NCT03151395 ·Status: COMPLETED ·Phase: NA